Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer

Clinical trial NCT01613768 · COMPLETED

Trial details

NCT number: NCT01613768
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Salivary Gland Cancer Stage IVA Salivary Gland Cancer Stage IVB Salivary Gland Cancer Stage IVC Salivary Gland Cancer

Start date: 2012-05-08
Primary completion: 2017-08-23
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.